(Q42906685)

10 November 2017

0 references

90Y/177Lu-DOTATATE therapy: survival of the fittest? (English)

1 reference

10 November 2017

Boudewijn Brans

1

1 reference

10 November 2017

Felix M Mottaghy

series ordinal

2

1 reference

10 November 2017

Alfons Kessels

series ordinal

3

1 reference

10 November 2017

1 October 2011

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

10 November 2017

1 reference

10 November 2017

38

1 reference

10 November 2017

10

1 reference

10 November 2017

1785-1787

1 reference

Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?

10 November 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168738

Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients.

27 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168738

Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides

16 August 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168738

Methodologic guidelines for reports of clinical trials

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21755369

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-011-1878-X

1 reference

release_3uqxuelnfzcnvij3n3ianmqgdy

10 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3uqxuelnfzcnvij3n3ianmqgdy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

10 November 2017

PubMed publication ID

21755369

1 reference